As Vice President of Products and Pricing at Constellation Energy, he was instrumental in demand side product development and market strategy. Additionally, Del co-founded Pyxis Energy ...

BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation ADC therapeutics for difficult-to-treat cancers, today announced ...

In a challenging year for biotech firms, Pyxis Oncology’s stock has touched a new 52-week low, sinking to $0.98. According to... Tuesday, Pyxis Oncology Inc. (NASDAQ:PYXS) saw its price target ...

Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Constellation Energy Corporation produces and sells energy products and services in the United States. It operates through five segments: Mid-Atlantic, Midwest, New York, ERCOT, and Other Power ...

See reviews below to learn more or submit your own review. Constellation provides energy solutions, specializing in electricity and natural gas. The company offers supply and management services ...